“Dapagliflozin in Heart Failure with Reduced Ejection Fraction (HFrEF): A Systematic Review of Its Mechanisms and Clinical Effectiveness” (2025) Journal of Pharmaceutical and Sciences, 8(4), pp. 2339–2347. doi:10.36490/journal-jps.com.v8i4.1121.